Celgene Corporation Cash from Operations Quarterly:
367.30M for March 31, 2013Celgene Corporation Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 367.30M |
| Dec. 31, 2012 | 490.39M |
| Sept. 30, 2012 | 580.75M |
| June 30, 2012 | 603.01M |
| March 31, 2012 | 344.40M |
| Dec. 31, 2011 | 437.64M |
| Sept. 30, 2011 | 602.07M |
| June 30, 2011 | 461.13M |
| March 31, 2011 | 275.27M |
| Dec. 31, 2010 | 204.84M |
| Sept. 30, 2010 | 381.66M |
| June 30, 2010 | 310.40M |
| March 31, 2010 | 284.65M |
| Dec. 31, 2009 | 320.56M |
| Sept. 30, 2009 | 277.25M |
| June 30, 2009 | 184.92M |
| March 31, 2009 | 127.12M |
| Dec. 31, 2008 | -294.16M |
| Sept. 30, 2008 | 217.74M |
| June 30, 2008 | 195.04M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
CELG Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Amgen | 1.049B |
| Biogen Idec | 178.94M |
| Gilead Sciences |
CELG Cash from Operations Quarterly Rankings
| Overall |
95th percentile 318 of 7593 |
| Sector |
96th percentile 22 of 650 in Healthcare |
| Industry |
98th percentile 3 of 237 in Biotechnology |
CELG Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -294.16M | Dec 2008 |
| Maximum | 603.01M | Jun 2012 |
| Average | 318.60M |
